Cardiex Ltd. logo

Cardiex Ltd. (CDX)

Market Closed
ASX ASX
39.71M Market Cap
- P/E Ratio
0% Div Yield
903,951 Volume
0 Eps
Want to track CDX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 3 days

Summary

CDX closed yesterday lower, a decrease of 7.32% from Thursday's close, completing a monthly increase of . Over the past 12 months, CDX stock gained .
CDX pays dividends to its shareholders, with the most recent payment made on Feb 09, 2007. The next estimated payment will be in 9 Feb 2007 on Feb 09, 2007 for a total of A$1.18.
The last earnings report, released on Feb 26, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports. The next scheduled earnings report is due on Jul 29, 2025.
Cardiex Ltd. has completed 1 stock splits, with the recent split occurring on Feb 18, 2022.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on ASX (AUD).

Cardiex Ltd. Dividends

Cardiex Ltd. logo
CDX 29 Jan 2007
Paid
Interim
A$1.18 Per Share

Cardiex Ltd. Earnings

29 Jul 2025 (In 3 days) Date
-
Cons. EPS
-
EPS
26 Feb 2025 Date
-
Cons. EPS
-
EPS
29 Nov 2024 Date
-
Cons. EPS
-
EPS
30 Aug 2024 Date
-
Cons. EPS
-
EPS
28 Aug 2024 Date
-
Cons. EPS
-
EPS
Cardiex Ltd. logo
CDX 29 Jan 2007
Paid
Interim
A$1.18 Per Share
29 Jul 2025 (In 3 days) Date
-
Cons. EPS
-
EPS
26 Feb 2025 Date
-
Cons. EPS
-
EPS
29 Nov 2024 Date
-
Cons. EPS
-
EPS
30 Aug 2024 Date
-
Cons. EPS
-
EPS
28 Aug 2024 Date
-
Cons. EPS
-
EPS

Cardiex Ltd. (CDX) FAQ

On which exchange is it traded?

Cardiex Ltd. is listed on ASX.

What is its stock symbol?

The ticker symbol is CDX.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, the market cap is 39.71M.

When is the next earnings date?

The next earnings report will release on Jul 29, 2025.

Has Cardiex Ltd. ever had a stock split?

Cardiex Ltd. had 1 splits and the recent split was on Feb 18, 2022.

Cardiex Ltd. Profile

Medical Devices Industry
Healthcare Sector
Mr. Craig R. Cooper BEC, L.L.B. CEO
ASX Exchange
AU0000015729 ISIN
Australia Country
- Employees
29 Jan 2007 Last Dividend
17 Feb 2022 Last Split
9 Nov 2005 IPO Date

Overview

CardieX Limited is a notable player in the medical device industry, focusing on the development, manufacturing, and marketing of devices aimed at the management of cardiovascular health. With its operations spanning across the Americas, Europe, and the Asia Pacific, the company has marked its presence on a global scale. Originally operating under the name AtCor Medical Holdings Limited, the company underwent a rebranding process to become CardieX Limited in June 2018. Since its inception in 1994 in Sydney, Australia, CardieX has dedicated itself to advancing cardiovascular health through innovative technology.

Products and Services

  • SphygmoCor Technology

    The cornerstone of CardieX Limited's product offering is the SphygmoCor technology, a patented vascular biometric system. This cutting-edge technology measures arterial health by collecting digital vascular biomarkers through novel sensors. It is designed to provide comprehensive insights into the cardiovascular system, making it a valuable tool for healthcare professionals in diagnosing and managing vascular health disorders.

  • Medical Devices and Vascular Biomarkers for Cardiovascular Management

    In addition to SphygmoCor, CardieX offers a range of medical devices and vascular biomarkers specifically tailored for the management of hypertension, cardiovascular disease, and other vascular health issues. These products are developed with the aim of enhancing patient care and outcomes by providing accurate and actionable health data.

  • Digital Solutions and Wearables for Home Health

    Understanding the growing demand for home-based healthcare solutions, CardieX has expanded its portfolio to include digital health products and wearables. These devices are designed for home health management, decentralized clinical trials, and remote patient monitoring, facilitating convenient and continuous care.

CardieX Limited's product and service range address a wide array of needs within the cardiovascular health management space, offering solutions for hospitals, clinics, research institutions, and pharmaceutical companies. Through its commitment to innovation and quality, CardieX aims to improve patient outcomes and the overall management of cardiovascular diseases globally.

Contact Information

Address: 55 Lime Street
Phone: 61 2 9874 8761